Zomanex

Zomanex is a drug formulation development company specializing in transforming intravenous, injectable, and oral therapeutics into novel orally delivered medicines. The company leverages its patented ORAZOM technology to enhance the absorption characteristics of therapeutics, specifically improving solubility and permeability. Zomanex focuses on Biopharmaceutical Classification System (BCS) Class II and Class IV therapeutics, selecting candidates based on established safety and efficacy data, successful outcomes in established medical indications, and potential to foster market growth globally. The company serves pharmaceutical and biotech firms looking to innovate their drug delivery methods. Zomanex operates in the global pharmaceutical market and generates revenue through partnerships and licensing agreements for its ORAZOM technology.

Keywords: drug formulation, ORAZOM technology, intravenous, injectable, oral therapeutics, solubility, permeability, BCS Class II, BCS Class IV, pharmaceutical innovation.